$363 Million is the total value of Veritas Investment Management (UK) Ltd's 35 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 14.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | Buy | UNITEDHEALTH GROUP | $30,477,000 | +67.2% | 114,558 | +54.2% | 8.40% | +41.9% |
| BRKB | Buy | BERKSHIRE HATHAWAY 'B'b class | $27,346,000 | +20.5% | 127,719 | +5.1% | 7.54% | +2.3% |
| MA | Buy | MASTERCARD 'A'cl a | $24,609,000 | +19.8% | 110,546 | +5.7% | 6.78% | +1.6% |
| TSM | Buy | TAIWAN SEMICONDUCTOR -ADR SPONS.-adr | $24,027,000 | +27.7% | 544,094 | +5.7% | 6.62% | +8.3% |
| FNV | Buy | FRANCO-NEVADA | $23,457,000 | -11.6% | 290,314 | +5.0% | 6.46% | -25.0% |
| LH | Buy | LABORATORY CORP AMERICA HOLDINGS | $22,117,000 | +13.4% | 127,342 | +17.2% | 6.09% | -3.8% |
| FISV | Buy | FISERV | $20,442,000 | +13.7% | 248,141 | +2.3% | 5.63% | -3.5% |
| CVS | Buy | CVS HEALTH | $19,933,000 | +32.4% | 253,210 | +8.2% | 5.49% | +12.3% |
| ACN | Buy | ACCENTURE 'A' | $19,151,000 | +21.7% | 112,519 | +16.9% | 5.28% | +3.2% |
| CTSH | Buy | COGNIZANT TECHNOLOGY SOLUTIONS'A'cl a | $18,563,000 | +2.6% | 240,613 | +5.1% | 5.12% | -12.9% |
| CERN | Buy | CERNER CORP | $17,154,000 | +28.7% | 266,332 | +19.5% | 4.73% | +9.2% |
| GOOG | Buy | ALPHABET 'C'cap stk cl c | $14,862,000 | +11.4% | 12,453 | +4.1% | 4.10% | -5.5% |
| New | XYLEM | $14,691,000 | – | 183,936 | +100.0% | 4.05% | – | |
| SLB | Buy | SCHLUMBERGER | $11,751,000 | -6.2% | 192,900 | +3.3% | 3.24% | -20.4% |
| AAPL | Buy | APPLE | $599,000 | +43.6% | 2,655 | +17.7% | 0.16% | +22.2% |
| WFC | New | WELLS FARGO | $118,000 | – | 2,248 | +100.0% | 0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-07
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 36 | Q4 2021 | 10.3% |
| BERKSHIRE HATHAWAY INC DEL | 36 | Q4 2021 | 14.4% |
| UNITEDHEALTH GROUP | 36 | Q4 2021 | 12.0% |
| LABORATORY CORP OF | 36 | Q4 2021 | 7.0% |
| ALTRIA GROUP | 36 | Q4 2021 | 3.6% |
| JPMORGAN CHASE & CO | 36 | Q4 2021 | 0.2% |
| FRANCO-NEVADA CORP | 34 | Q4 2021 | 10.0% |
| WELLS FARGO & CO NEW | 34 | Q4 2021 | 0.2% |
| HONEYWELL INTL INC | 29 | Q2 2021 | 1.7% |
| PHILIP MORRIS INTL | 28 | Q4 2019 | 5.0% |
View Veritas Investment Management (UK) Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-05 |
| 13F-HR | 2021-05-14 |
| 13F-HR | 2021-02-11 |
| 13F-HR | 2020-11-02 |
| 13F-HR | 2020-08-06 |
| 13F-HR/A | 2020-05-06 |
| 13F-HR | 2020-05-06 |
View Veritas Investment Management (UK) Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.